Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. - Wikidata - wikimedia - TriplyDB

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

http://www.wikidata.org/entity/Q39916475

about

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 Identification of differentially expressed microRNAs in human male breast cancer MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer Recent advances in the molecular understanding of glioblastoma A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics MicroRNA Regulation of Human Breast Cancer Stem Cells Common stemness regulators of embryonic and cancer stem cells Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs Glioblastoma Circulating Cells: Reality, Trap or Illusion?Regulation of ovarian cancer stem cells or tumor-initiating cells MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours Brain tumor stem cells: Molecular characteristics and their impact on therapy The Role of microRNAs in Stemness of Cancer Stem Cells Targeting glioma stem cells: a novel framework for brain tumors Glioblastoma genetics: in rapid flux.MicroRNAs targeting prostate cancer stem cells Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer Let-7 microRNA inhibits the proliferation of human glioblastoma cells GSK3beta regulates differentiation and growth arrest in glioblastoma Structural and logical analysis of a comprehensive hedgehog signaling pathway to identify alternative drug targets for glioma, colon and pancreatic cancer A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling Strategies of eradicating glioma cells: a multi-scale mathematical model with MiR-451-AMPK-mTOR control The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death p38α mitogen-activated protein kinase depletion and repression of signal transduction to translation machinery by miR-124 and -128 in neurons A catalogue of glioblastoma and brain MicroRNAs identified by deep sequencing GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors Overcoming therapeutic resistance in glioblastoma: the way forward Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?The role of microRNAs in glioma initiation and progression.

P2860

Q21245764-65BC112E-02AB-4EDC-9AE5-1D2347223DD2 Q21261330-A3112C5B-DA8C-4E18-9620-DE1FE6886996 Q24603505-A8212996-B99A-48E5-B9BE-1136A3BAE7BD Q24629145-0B62691A-9408-473B-90D8-61E005BC3A54 Q24632636-2A890682-F63A-4738-A4E0-CA4A93ABCD4B Q24632928-32F2FC9C-F0B4-4486-856E-BBDC97CB6AC5 Q24633772-61793F09-B165-44EB-87D7-3158BC22B6FC Q26747273-98A68602-3A0C-4EA1-A06A-7E99968AC90D Q26771792-E7D9ECB7-B798-4182-BDE1-BB2BCDAC9950 Q26777882-13DF6003-36AE-4C3C-A527-A7E03EFA9D0F Q26796590-8FAECAC2-B385-46C8-AFD6-8133582AF05B Q26822987-E80414F0-F584-4D28-9D9E-31B3EB32B815 Q26823823-C79C68D5-0B37-4A9F-8709-5C41530B4F31 Q26853096-480B2275-BE4C-49D3-82FD-B1E31E079A27 Q26865287-F646875D-3D03-43DE-9D05-83555B7B1A6F Q26995698-D3E6318A-9D8B-47A8-901B-2F3A866337E2 Q27002604-48ED47BF-88D8-44C1-B4C7-F94D31599C25 Q27003138-B6F62BFF-D84E-4C4B-8910-814B72DF23E2 Q27005618-CD699E9B-7F6A-4C67-B88B-90743BA08739 Q27026818-CE16CDE4-A48B-4DA4-9B72-039800F693D3 Q27691826-EDB1B50F-DA75-43C8-8C87-D19E7BE30D53 Q28081039-B8F22E64-09CE-4B57-A12E-D13F41BC6111 Q28248085-1726989B-93A6-4EEB-A41E-8ABD62F3BA5C Q28267167-734D14D0-8AAA-4F47-B91E-A42FFE7F4BDD Q28282860-3F2398E5-94A4-4275-B0B7-F31A2F9E472B Q28287254-817BC4CE-DE6C-4640-81C3-52033D3D6533 Q28476300-56E0F19E-CC02-4E9E-B17B-48BCAFFE1670 Q28534771-222367AD-BC09-4E1C-A86B-D17208935CB5 Q28537845-7D364C3D-CCFA-42AC-A916-9A2186D0108B Q28543125-D6FF8B43-ECF2-4C7A-9484-0837657EC6A9 Q28554467-45093AAB-31C5-400D-B72A-0EBABEEFD8D7 Q28710107-24356435-A5F9-4B5E-9FE5-4963F980F00C Q28710348-42B9D630-87C8-4CA7-BB38-7863256F2002 Q28730123-C53A68D1-467B-4337-ABB4-BDE972954EB9 Q29248396-54DBC38C-2780-407D-A77C-D1B2374200B2 Q30405446-05F7225F-7B14-45E1-B70E-DF57BAEAD698 Q30405560-DB867D60-4438-484B-9238-4414004C03CB Q30413140-38240F37-2459-406B-A8FB-57C0029427F5 Q30426792-C742FE10-303D-42F5-AEC4-098D8FAB9EA9 Q30428370-B06A3C2F-21C7-4087-BDD0-3EB83FA30B0F

P2860

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

http://www.wikidata.org/entity/Q39916475

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Targeting of the Bmi-1 oncogen ...... roliferation and self-renewal.

@en

Targeting of the Bmi-1 oncogen ...... roliferation and self-renewal.

@nl

type

label

Targeting of the Bmi-1 oncogen ...... roliferation and self-renewal.

@en

Targeting of the Bmi-1 oncogen ...... roliferation and self-renewal.

@nl

prefLabel

Targeting of the Bmi-1 oncogen ...... roliferation and self-renewal.

@en

Targeting of the Bmi-1 oncogen ...... roliferation and self-renewal.

@nl

P1433

Q39916475-D49CDB72-3897-48F5-9517-26F857789B4E

P1476

Q39916475-642682EE-8797-42B2-AD39-8F11AB2F7949

P2093

Q39916475-156A8EBA-C682-485F-9DDC-64F46FE28DA5

Q39916475-410A2A7B-FE42-4D54-81F3-2FB091EBC97B

Q39916475-65AC3C6E-9BDB-472F-87F0-15B44F0041FE

Q39916475-76E25320-1241-46D9-9CF4-5C4849D22DE6

Q39916475-93D8B9B2-60C0-4CE4-828C-058E1F960016

Q39916475-9BAE1F4D-0062-426A-9A2E-7518F6E56C4E

Q39916475-A9EACB25-BFF4-479D-AFCC-A7EC5ECB7C37

Q39916475-D933A72D-0832-47D9-AD10-6BC0AC6D4AEE

Q39916475-FABB79A0-BCD4-4AF5-BCB6-0418B278521E

P304

Q39916475-EE2C7B32-F251-4057-9F27-6FDFF6CC0FD5

P31

Q39916475-0F0F0E80-C59A-4EC1-A7F4-EDE0C101E7B2

P356

Q39916475-D16AC0AA-3A7B-4B1A-9F78-2AA7F19881F5

P407

Q39916475-31EE310B-E310-4447-8920-FC647082FDFF

P433

Q39916475-4FA76A63-E64B-41A8-BD9F-D96406992750

P478

Q39916475-2E303994-8BA9-4047-8FCF-91AFF0A1005F

P50

Q39916475-BAB1118D-15D7-4D0B-B0DA-60FA800BBB97

P577

Q39916475-3B8F2FEC-CA8A-4A4D-82E1-8D3EB66F6EAF

P5875

Q39916475-02EFB715-1BC3-4DF8-BDB4-9E636AC9CD88

P698

Q39916475-61E1CA51-EA31-43A3-8018-E46926141D3C

P921

Q39916475-71582BC4-CEDB-4E97-B263-7C17DBB81C22

P356

0008-5472.CAN-08-2629

P1433

Cancer Research

P1476

Targeting of the Bmi-1 oncogen ...... roliferation and self-renewal.

@en

P2093

Abhik Raychaudhury

http://www.w3.org/2001/XMLSchema#string

Akihiro Otsuki

http://www.w3.org/2001/XMLSchema#string

E Antonio Chiocca

http://www.w3.org/2001/XMLSchema#string

Gerard Nuovo

http://www.w3.org/2001/XMLSchema#string

Herbert B Newton

http://www.w3.org/2001/XMLSchema#string

Jakub Godlewski

http://www.w3.org/2001/XMLSchema#string

Michal O Nowicki

http://www.w3.org/2001/XMLSchema#string

Sean Lawler

http://www.w3.org/2001/XMLSchema#string

Shanté Williams

http://www.w3.org/2001/XMLSchema#string

P304

9125-9130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-2629

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Agnieszka Bronisz

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23475215

http://www.w3.org/2001/XMLSchema#string

P698

19010882

http://www.w3.org/2001/XMLSchema#string

P921